dopamine: be used in neonates

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents neurotransmitter
Weight: 0.73
, chemical
Weight: 0.69
, hormone
Weight: 0.68
, neuron
Weight: 0.67
, drug
Weight: 0.67
Siblings acetylcholine
Weight: 0.41
, serotonin
Weight: 0.41
, vasopressin
Weight: 0.39
, oxytocin
Weight: 0.39
, norepinephrine
Weight: 0.38

Related properties

Property Similarity
be used in neonates 1.00
be contraindicated in pheochromocytoma 0.77
be used for bradycardia 0.77
be used in acute renal failure 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Salient implies Plausible

0.20
Rule weight: 0.28
Evidence weight: 0.72
Similarity weight: 1.00
Evidence: 0.31
Plausible(dopamine, be used in neonates)
Evidence: 0.41
¬ Salient(dopamine, be used in neonates)

Similarity expansion

0.60
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.77
Evidence: 0.78
Remarkable(dopamine, be used in neonates)
Evidence: 0.35
¬ Remarkable(dopamine, be used for bradycardia)
0.59
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.75
Evidence: 0.78
Remarkable(dopamine, be used in neonates)
Evidence: 0.34
¬ Remarkable(dopamine, be used in acute renal failure)
0.57
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.77
Evidence: 0.78
Remarkable(dopamine, be used in neonates)
Evidence: 0.61
¬ Remarkable(dopamine, be contraindicated in pheochromocytoma)
0.55
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.77
Evidence: 0.41
Salient(dopamine, be used in neonates)
Evidence: 0.26
¬ Salient(dopamine, be used for bradycardia)
0.54
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.77
Evidence: 0.31
Plausible(dopamine, be used in neonates)
Evidence: 0.26
¬ Plausible(dopamine, be used for bradycardia)
0.50
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.75
Evidence: 0.41
Salient(dopamine, be used in neonates)
Evidence: 0.37
¬ Salient(dopamine, be used in acute renal failure)
0.46
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.77
Evidence: 0.19
Typical(dopamine, be used in neonates)
Evidence: 0.36
¬ Typical(dopamine, be used for bradycardia)
0.44
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.75
Evidence: 0.31
Plausible(dopamine, be used in neonates)
Evidence: 0.45
¬ Plausible(dopamine, be used in acute renal failure)
0.42
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.77
Evidence: 0.41
Salient(dopamine, be used in neonates)
Evidence: 0.63
¬ Salient(dopamine, be contraindicated in pheochromocytoma)
0.40
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.77
Evidence: 0.31
Plausible(dopamine, be used in neonates)
Evidence: 0.56
¬ Plausible(dopamine, be contraindicated in pheochromocytoma)
0.34
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.77
Evidence: 0.19
Typical(dopamine, be used in neonates)
Evidence: 0.59
¬ Typical(dopamine, be contraindicated in pheochromocytoma)
0.33
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.75
Evidence: 0.19
Typical(dopamine, be used in neonates)
Evidence: 0.59
¬ Typical(dopamine, be used in acute renal failure)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.41
Salient(dopamine, be used in neonates)
Evidence: 0.19
¬ Typical(dopamine, be used in neonates)
Evidence: 0.78
¬ Remarkable(dopamine, be used in neonates)

Typical implies Plausible

0.41
Rule weight: 0.48
Evidence weight: 0.87
Similarity weight: 1.00
Evidence: 0.31
Plausible(dopamine, be used in neonates)
Evidence: 0.19
¬ Typical(dopamine, be used in neonates)